TY - JOUR
T1 - The Japanese Society of Pathology Guidelines on the handling of pathological tissue samples for genomic research
T2 - Standard operating procedures based on empirical analyses
AU - Kanai, Yae
AU - Nishihara, Hiroshi
AU - Miyagi, Yohei
AU - Tsuruyama, Tatsuhiro
AU - Taguchi, Kenichi
AU - Katoh, Hiroto
AU - Takeuchi, Tomoyo
AU - Gotoh, Masahiro
AU - Kuramoto, Junko
AU - Arai, Eri
AU - Ojima, Hidenori
AU - Shibuya, Ayako
AU - Yoshida, Teruhiko
AU - Akahane, Toshiaki
AU - Kasajima, Rika
AU - Morita, Kei Ichi
AU - Inazawa, Johji
AU - Sasaki, Takeshi
AU - Fukayama, Masashi
AU - Oda, Yoshinao
N1 - Funding Information:
This article was supported by “The Tailor-Made Medical Treatment Program (17km0305003h0005)” which is a project sponsored by the Japan Agency for Medical Research and Development (AMED). The authors are grateful to the many technical staff working in our laboratories for their laborious work, clinicians for approving the usage of tissue samples for this study, and members of the Advisory Council for developing The Guidelines on the Handling of Pathological Tissue Samples for Genomic Research, Drs. Hitoshi Nakagama (NCBN), Daisuke Matsubara (BBJ), Shumpei Niida (NCBN), Yu-ichi Goto (NCBN), Katsushige Yamashiro (NHO), Norihiro Teramoto (NHO), Chiyoe Kita-gawa (NHO), Yasuhiro Matsumura (JCOG), Dai Shida (JCOG), Kenichi Nakamura (JCOG), Hajime Okita (JCCG), Eizo Hiyama (JCCG), Takashi Komori (JCCG), Yoshio Miki (JCA) and Atsushi Ochiai (JCA), for critical discussion and constructive suggestions.
Publisher Copyright:
© 2018 The Authors. Pathology International published by Japanese Society of Pathology and John Wiley & Sons Australia, Ltd
PY - 2018/2
Y1 - 2018/2
N2 - Genome research using appropriately collected pathological tissue samples is expected to yield breakthroughs in the development of biomarkers and identification of therapeutic targets for diseases such as cancers. In this connection, the Japanese Society of Pathology (JSP) has developed “The JSP Guidelines on the Handling of Pathological Tissue Samples for Genomic Research” based on an abundance of data from empirical analyses of tissue samples collected and stored under various conditions. Tissue samples should be collected from appropriate sites within surgically resected specimens, without disturbing the features on which pathological diagnosis is based, while avoiding bleeding or necrotic foci. They should be collected as soon as possible after resection: at the latest within about 3 h of storage at 4°C. Preferably, snap-frozen samples should be stored in liquid nitrogen (about −180°C) until use. When intending to use genomic DNA extracted from formalin-fixed paraffin-embedded tissue, 10% neutral buffered formalin should be used. Insufficient fixation and overfixation must both be avoided. We hope that pathologists, clinicians, clinical laboratory technicians and biobank operators will come to master the handling of pathological tissue samples based on the standard operating procedures in these Guidelines to yield results that will assist in the realization of genomic medicine.
AB - Genome research using appropriately collected pathological tissue samples is expected to yield breakthroughs in the development of biomarkers and identification of therapeutic targets for diseases such as cancers. In this connection, the Japanese Society of Pathology (JSP) has developed “The JSP Guidelines on the Handling of Pathological Tissue Samples for Genomic Research” based on an abundance of data from empirical analyses of tissue samples collected and stored under various conditions. Tissue samples should be collected from appropriate sites within surgically resected specimens, without disturbing the features on which pathological diagnosis is based, while avoiding bleeding or necrotic foci. They should be collected as soon as possible after resection: at the latest within about 3 h of storage at 4°C. Preferably, snap-frozen samples should be stored in liquid nitrogen (about −180°C) until use. When intending to use genomic DNA extracted from formalin-fixed paraffin-embedded tissue, 10% neutral buffered formalin should be used. Insufficient fixation and overfixation must both be avoided. We hope that pathologists, clinicians, clinical laboratory technicians and biobank operators will come to master the handling of pathological tissue samples based on the standard operating procedures in these Guidelines to yield results that will assist in the realization of genomic medicine.
KW - biobank
KW - empirical analysis
KW - genome research
KW - pathological tissue sample
KW - sample collection and storage
UR - http://www.scopus.com/inward/record.url?scp=85042140626&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042140626&partnerID=8YFLogxK
U2 - 10.1111/pin.12631
DO - 10.1111/pin.12631
M3 - Article
C2 - 29431262
AN - SCOPUS:85042140626
SN - 1320-5463
VL - 68
SP - 63
EP - 90
JO - Acta Pathologica Japonica
JF - Acta Pathologica Japonica
IS - 2
ER -